News for '-trastuzumab-deruxtecan'

Cancer Therapies Break New Ground

Cancer Therapies Break New Ground

Rediff.com26 Dec 2025

'India is clearly moving toward more targeted treatment pathways in high-burden cancers.'

Health budget up by 11%, daycare cancer centres announced

Health budget up by 11%, daycare cancer centres announced

Rediff.com1 Feb 2025

The Union health ministry has been allocated Rs 99,858.56 crore in the Budget 2025-2026, an around 11 per cent hike over the Rs 89,974.12 crore in the budget (revised estimates) of 2024-2025 with the government announcing setting up daycare cancer centres at all district hospitals over the next three years.

Highest Selling New Drug In India Is...

Highest Selling New Drug In India Is...

Rediff.com11 Feb 2025

Enhertu currently costs around Rs 1.6 lakh per 100-milligram injection.

Budget 2024: What is cheaper, what is costlier

Budget 2024: What is cheaper, what is costlier

Rediff.com23 Jul 2024

Gold, silver and other precious metals along with imported mobile phones, certain cancer drugs and medical devices are set to become cheaper with Finance Minister Nirmala Sitharaman announcing cuts in customs duty in the Union Budget 2024-25.

Govt cuts customs duty on 3 cancer drugs

Govt cuts customs duty on 3 cancer drugs

Rediff.com23 Jul 2024

The government proposes to cut custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to nil.

What Sitharaman's 7th Budget has in store for us

What Sitharaman's 7th Budget has in store for us

Rediff.com23 Jul 2024

Highlights of the Union Budget 2024-25 presented by Finance Minister Nirmala Sitharaman in Lok Sabha on Tuesday.